Literature DB >> 26122095

Weight loss interventions and progression of diabetic kidney disease.

Neil G Docherty1, Aoife L Canney, Carel W le Roux.   

Abstract

Progressive renal impairment (diabetic kidney disease (DKD)) occurs in upwards of 40 % of patients with obesity and type 2 diabetes mellitus (T2DM) and is a cause of significant morbidity and mortality. Means of attenuating the progression of DKD focus on amelioration of risk factors. Visceral obesity is implicated as a causative agent in impaired metabolic and cardiovascular control in T2DM, and various approaches primarily targeting weight have been examined for their impact on markers of renal injury and dysfunction in DKD. The current report summarises the evidence base for the impact of surgical, lifestyle and pharmacological approaches to weight loss on renal end points in DKD. The potential for a threshold of weight loss more readily achievable by surgical intervention to be a prerequisite for renal improvement is highlighted. Comparing efficacious non-surgical weight loss strategies with surgical strategies in appropriately powered and controlled prospective studies is a priority for the field.

Entities:  

Mesh:

Year:  2015        PMID: 26122095     DOI: 10.1007/s11892-015-0625-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  54 in total

1.  Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.

Authors:  Varun Agrawal; Kevin R Krause; David L Chengelis; Kerstyn C Zalesin; Leslie L Rocher; Peter A McCullough
Journal:  Surg Obes Relat Dis       Date:  2008-08-05       Impact factor: 4.734

Review 2.  Mechanisms of diabetic complications.

Authors:  Josephine M Forbes; Mark E Cooper
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

3.  Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery.

Authors:  Antonio Amor; Amanda Jiménez; Violeta Moizé; Ainitze Ibarzabal; Lílliam Flores; Antonio M Lacy; Josep Vidal
Journal:  Surg Endosc       Date:  2013-01-05       Impact factor: 4.584

4.  Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.

Authors:  John P Bantle; Judith Wylie-Rosett; Ann L Albright; Caroline M Apovian; Nathaniel G Clark; Marion J Franz; Byron J Hoogwerf; Alice H Lichtenstein; Elizabeth Mayer-Davis; Arshag D Mooradian; Madelyn L Wheeler
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

5.  Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.

Authors:  Allon N Friedman; Mary Chambers; Lisa M Kamendulis; Joan Temmerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

6.  Kidney disease and increased mortality risk in type 2 diabetes.

Authors:  Maryam Afkarian; Michael C Sachs; Bryan Kestenbaum; Irl B Hirsch; Katherine R Tuttle; Jonathan Himmelfarb; Ian H de Boer
Journal:  J Am Soc Nephrol       Date:  2013-01-29       Impact factor: 10.121

Review 7.  Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes.

Authors:  Swasti Tiwari; Shahla Riazi; Carolyn A Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-08

Review 8.  Microalbuminuria and cardiovascular disease.

Authors:  Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-14       Impact factor: 8.237

9.  Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes.

Authors:  Alexander D Miras; Ling Ling Chuah; Gerassimos Lascaratos; Sana Faruq; Ajay A Mohite; Priya R Shah; Mahi Gill; Sabrina N Jackson; Desmond G Johnston; Torsten Olbers; Carel W le Roux
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

10.  Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

Authors:  Samantha Scholtz; Alexander D Miras; Navpreet Chhina; Christina G Prechtl; Michelle L Sleeth; Norlida M Daud; Nurhafzan A Ismail; Giuliana Durighel; Ahmed R Ahmed; Torsten Olbers; Royce P Vincent; Jamshid Alaghband-Zadeh; Mohammad A Ghatei; Adam D Waldman; Gary S Frost; Jimmy D Bell; Carel W le Roux; Anthony P Goldstone
Journal:  Gut       Date:  2013-08-20       Impact factor: 31.793

View more
  8 in total

1.  1,3-Butanediol attenuates hypertension and suppresses kidney injury in female rats.

Authors:  Jeanne A Ishimwe; Michael R Garrett; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-08

Review 2.  Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?

Authors:  Nia S Mitchell; Julia J Scialla; William S Yancy
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

Review 3.  The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?

Authors:  Dora M Gorman; Carel W le Roux; Neil G Docherty
Journal:  Diabetes Metab J       Date:  2016-09-27       Impact factor: 5.376

4.  The essential function of CARD9 in diet-induced inflammation and metabolic disorders in mice.

Authors:  Xuejiao Zeng; Xihao Du; Jia Zhang; Shuo Jiang; Jie Liu; Yuquan Xie; Wei Shan; Guanglong He; Qinghua Sun; Jinzhuo Zhao
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

5.  Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus.

Authors:  Seigo Sugiyama; Hideaki Jinnouchi; Noboru Kurinami; Kunio Hieshima; Akira Yoshida; Katsunori Jinnouchi; Motoko Tanaka; Hiroyuki Nishimura; Tomoko Suzuki; Fumio Miyamoto; Keizo Kajiwara; Tomio Jinnouchi
Journal:  J Clin Med Res       Date:  2018-04-13

6.  Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients With Obesity and Mild Kidney Failure.

Authors:  Adriano Bruci; Dario Tuccinardi; Rossella Tozzi; Angela Balena; Silvia Santucci; Riccardo Frontani; Stefania Mariani; Sabrina Basciani; Giovanni Spera; Lucio Gnessi; Carla Lubrano; Mikiko Watanabe
Journal:  Nutrients       Date:  2020-01-27       Impact factor: 5.717

7.  Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.

Authors:  Clarissa J Diamantidis; Hayden B Bosworth; Megan M Oakes; Clemontina A Davenport; Jane F Pendergast; Sejal Patel; Jivan Moaddeb; Huiman X Barnhart; Peter D Merrill; Khaula Baloch; Matthew J Crowley; Uptal D Patel
Journal:  Contemp Clin Trials       Date:  2018-04-10       Impact factor: 2.226

8.  A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities.

Authors:  Anna Permyakova; Asaad Gammal; Liad Hinden; Michal Weitman; Marta Weinstock; Joseph Tam
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.